Lumida
/GL
⌘K
Globe Life Inc

Globe Life Inc

GL
$184.76USD↑+0.11%+0.20 today

MARKET CAP

14.3B

P/E (TTM)

12.4x

FWD P/E

10.9x

DAY RANGE

$184 – $192

52W RANGE

$119
$192

AI Summary

Stalk
StalkMedium

Yesterday’s medium-term bearish bias was overturned by a decisive breakout above the prior resistance zone around ~184 that held on standout volume. Stage 2 remains advancing with a fresh Momentum Breakout, supporting a bullish medium-term bias. However, price is extended above the rising 9/21 EMAs and extreme overbought short-term, so deferred entries on pullbacks into the confluence of EMAs and the resistance-turned-support area (~180–184) are preferred.

  • ↑Q1 net income rose 6% to $271M ($3.39 EPS) with double-digit operating income growth
  • ↑Projected health premium revenue up 14–17% in 2026, driven by Medicare supplement demand
  • ↓Lapse rates expected to stay elevated in 2026, pressuring policy retention and revenue
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Globe Life Inc. (NYSE: GL) is a prominent player in the life and health insurance markets, offering a variety of insurance products primarily aimed at underserved lower-middle to middle-income households. The company operates multiple subsidiaries such as American Income Life and Liberty National, providing straightforward policies that cater to financial security needs. Globe Life is poised to benefit from the growing demand for Medicare supplement plans due to the increasing aging population and the continued under-insurance across the United States, positioning itself as a leader in the rapidly evolving insurance sector.

Bull says

  • ↑Q1 net income rose 6% to $271M ($3.39 EPS) with double-digit operating income growth
  • ↑Projected health premium revenue up 14–17% in 2026, driven by Medicare supplement demand
  • ↑Share buybacks of $205M in Q1 and $560–610M authorizations support shareholder returns
  • ↑ROE of 20–22% and high earnings yield with positive momentum factors underpin valuation
  • ↑AI-driven underwriting and admin efficiency initiatives aim to cut costs and boost margins
  • ↑Free cash flow forecast of $650–700M for 2026 underpins capital return capacity

Bear says

  • ↓Lapse rates expected to stay elevated in 2026, pressuring policy retention and revenue
  • ↓Negative growth and revision trends signal potential revenue slowdown versus guidance
  • ↓Medicare supplement regulatory changes could introduce margin volatility and sales headwinds
  • ↓Aggressive buybacks risk liquidity strain if unexpected costs arise, hampering growth funding
  • ↓Exposure to volatility and weak liquidity factors may increase stock price fluctuations
  • ↓Balance sheet vulnerabilities highlighted by low liquidity factor could challenge long-term stability

Investment themes with GL

L&H Insurance↑ +0.32%

PGR · TRV · ALL

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 04-23-2026bullish

Transcript signals

Bull points

  • In the first quarter, net income was $271 million, or $3.39 per share, compared to $255 million, or $3.01 per share, a year ago.
  • Net operating income for the quarter was $274 million, or $3.43 per share, an increase of 12% over the $3.07 per share from a year ago.
  • Despite the challenges faced by working-class Americans in the current economic environment, Gold Life has now produced double-digit growth in net operating income per share in seven of the last eight quarters.

Bear points

  • Administrative expenses were $94 million for the quarter, an increase of approximately 8% over the first quarter of 2025.
  • 11,064, down 4% from a year ago, due primarily to a decline in new agent retention
  • Net health sales were $7 million, down 3% from the year-ago quarter as more emphasis has been placed on life business
Read full transcript analysis ›